Parian Global Management LP Biodesix Inc Transaction History

Parian Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.69 - $5.81 $669,625 - $2.3 Million	-396,228 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.09 - $8.67 $492,374 - $1.04 Million	-120,385 Reduced 23.3%	396,228 $2.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $1.96 Million - $3.8 Million	297,284 Added 135.54%	516,613 $4.25 Million
Q2 2021 Aug 16, 2021	BUY	$12.14 - $20.35 $1.25 Million - $2.1 Million	103,232 Added 88.92%	219,329 $2.9 Million
Q1 2021 May 17, 2021	BUY	$16.87 - $31.21 $1.96 Million - $3.62 Million	116,097 New	116,097 $2.36 Million

53.6M

500

11.5K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $68.4M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Parian Global Management LP with notifications on news.